Cardiovascular Flashcards

1
Q

Hypertension

A

Normal Blood pressure
- Systolic less than 120 and Diastolic less than 90

Hypertension Stage 1
- Systolic between 130-139 and Diastolic between 80-89

Hypertension Stage 2
- Systolic at least 140 OR a diastolic at least 90

Diagnosis:
- Ambulatory blood pressure monitoring (ABPM) is considered gold standard for diagnosing hypertension
- If the patient has one or more of the following criteria using ABPM, this indicated hypertension
1) Criteria include a 24 hour mean of either a systolic of 125 or greater OR a diastolic of 75 or greater
2) Day time or awake time mean of either a systolic of 130 or greater or a diastolic of 80 or greater
3) Night time or asleep time mean of either a systolic of 110 or greater or a diastolic of 65 or greater

ONLY circumstances where out of office confirmatory readings are NOT required
1) When a patient present with a hypertensive crisis (SBP 180 or greater or a DBP 120 or greater)
2) When a patient presents with a SBP of 160 or greater or a DNP of 100 or greater who also have known target end organ damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hypertension Treatment

A

Non-pharmacological treatment
- Dietary salt restriction, weight loss, exercise and limiting alcohol intake

Pharmacological treatment:
- First line agents:
- Angiotensin converting enzyme inhibitors (ACEI)
- Angiotensin II receptor blockers (ARBs)
- Calcium channel blockers (CCBs)
- Thiazide diuretics

Expert recommendations:
- Single drug therapy is unlikely to be successful in the treatment of hypertension if a patients blood pressure is more than 20/10 above the goal
- UpToDate recommends patients with a sBP of 140 or greater or a DBP of 90 or greater should be started on combination therapy
- First choice: ACE or ARB - Dihydropyridine CCB
- Thiazide preferred over CCB: patients with edema, osteoporosis or calcium nephrolithiasis
- Chlorthalidone or indapamide preferred over hydrochlorothiazide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Angiotensin Converting Enzyme Inhibitors (ACEIs)

A
  • Used in the treatment of hypertension
  • Preferred option in patients with chronic kidney disease and heart failure

Examples: Lisinopril, Benazepril, Captopril, Enalapril

Side effects: Related to either decreased angiotensin II or increased kinins
- Decreased angiotensin II
- Hypotension, acute kidney injury, hyperkalemia and pregnancy complications
- If hyperkalemia occurs and is unable to be managed or if creatinine increased >30% baseline, within the first 6-8 weeks, ACE termination should be considered.
- Increased Kinins
- Dry hacking cough, angioedema (rare but life threatening)

Important points
- Contraindicated in pregnancy
- ACE inhibitors and ARBs can NOT be taken together

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Angiotensin II receptor blockers (ARBs)

A
  • Used in the treatment of hypertension
  • Preferred option in patients with chronic kidney disease and heart failure

Examples: Losartan, Valsartan, Candesartan

Side effects:
- Higher rates of hypotension symptoms compared to ACEIs
- ARBs are LESS likely than ACEIs to cause a cough and angioedema

Important points:
- Contraindicated in pregnancy
- ACEIs and ARBs can NOT be taken together

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hypertensive Medications in Pregnancy

A

“New Little Mama”

N - Nifedipine
L - Labetaolol
M - Methyldopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Calcium Channel Blockers

A
  • Can be used as monotherapy or adjunct
  • Significant amount of data supporting CCBs reduction in subsequent cardiac events
  • Metabolized through the CYP450 system

NON-Dihydropyridines
- Weaker vasodilator, works more to decrease the contractility of the heart
- Used for hypertensions (less frequently), chronic stable angina, cardiac arrhythmias

Examples: Verapamil and Diltiazem

Side effects: Constipation, bradycardia, decreased cardiac output, gingival hyperplasia

Dihydropyridines
- Potent vasodilators with minimal cardiac effects
- Used for hypertension or chronic stable angina

Examples: Amlodipine, Nifedipine, Nicardipine

Side effects
- Headache, lightheadedness, flushing, dependent peripheral edema, gingival hyperplasia
- Treat peripheral edema by reducing CCB dose, switching to a non-Dihydropyridines and/or add a RAS-block agent (ACE or ARB)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Thiazide Diuretics

A
  • Thiazide like diuretics are more effective at treating hypertension and reducing cardiac events and mortality when compared to hydrochlorothiazide

Examples:
- Hydrochlorothiazide (HCTZ)
- Caution with elderly, Caucasian patients (increased risk of skin CA), renal or hepatic impairment, arrhythmias, diabetes mellitus, seizure disorder, history of gout, pancreatitis.
- Thiazide-like diuretics
- Chlorthalidone, indapamide

Side effects:
- Dose dependent side effects: Hypokalemia, hyponatremia, hypomagnesemia, hyperuricemia, hyperglycemia and hyperlipidemia
- Decreased risk of hypokalemia by:
- Maintaining low sodium diet
- Combining with an ACE or ARB
- Avoid combing HCTZ with a CCB as this may cause acquired neutropenia
- Non-dose dependent side effects: sleep disturbances and sexual dysfunction

Contraindications:
- Sulfa allergy and anuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Alpha-1 Blockers

A

Examples: Terazosin, Tamsulosin, Alfuzosin, Silodosin
- Terazosin is useful for patients with benign prostatic hyperplasia (BPH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Beta Blockers

A

Examples: Labetalol, Carvedilol, Propranolol, Nebivolol
- Labetaolol is drug of choice for pregnant patients with hypertension
- IF contraindicated, other options include methyldopa and nifedipine

Contraindications to Beta Blockers:
- Severe bradycardia, AV Block, 2nd-3rd degree, decompensated heart failure, sick sinus syndrome, asthma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Complications of Hypertension

A
  • Hypertension is considered the most significant, modifiable risk factor for cardiac disease
  • Hypertension is associated with an increased risk of stroke, coronary artery disease, heart failure, atrial fibrillation, abdominal aortic aneurysm, and peripheral vascular disease.

Mild retinal microvascular changes
- Retinal arteriolar narrowing and arteriovenous nicking also referred to as “nipping”

Moderate retinal microvascular changes
- Hemorrhages, either flame or dot-shaped, cotton-wool spots, hard exudates, and micro aneurysms

Severe retinal microvascular changes
- all previous retinal changes PLUS papilledema (optic disc edema)
- Papilledema
- Consequence of intracranial hypertension
- Early symptoms: very brief episodes of vision loss, loss of spontaneous venous pulsations, optic disc is retained
- Late symptoms: Optic disc becomes elevated, the cup is completely destroyed, disc margins become obscured, edema extends into the retina, multiple flame hemorrhages and common wool spots.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dyslipidemia

A

Abnormally elevated cholesterol or lipids and is a risk factor for atherosclerotic cardiovascular disease

Treatment:
- Statin therapy is first line
- Examples: Lovastatin, pravastatin, simvastatin, fluvastatin, Atorvastatin, Rosuvastatin
- Statins are contraindicated in pregnancy

Indications for a statin
- LDL-C >190
- LDL-C <190, the indication for statin therapy is dependent on their risk for a cardiac event in the next 10 years.
- Intermediate risk for cardiovascular disease
- 5 to 7.4% risk of a cardiac event within the next 10 years and a LDL of 100 to <190.
- Literature recommends to initiate a stating
- Discuss risk and benefits
- High to very high risk for cardiovascular disease
- >7.5% risk for a cardiac event in the next 10 years and a LDL 100 to <190
- Initiated moderate intensity statin
- Initiated high intensity statin if risk for cardiac event is >20%

Important points
- After starting a stain, it is recommended to measure the patients LDL-C response at 4-6 weeks after starting therapy and every 12 months thereafter
- The goal is to get the LDL < 100
- Statins are contraindicated in pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Statin Therapy (Low Intensity)

A

Lovastatin 20mg

Pravastatin 10 to 20mg

Simvastatin 10mg

Fluvastatin 20 to 40mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Statin Therapy (Moderate Intensity)

A

Lovastatin 40 to 80mg

Pravastatin 40 to 80mg

Simvastatin 20 to 40mg

Atorvastatin 10 to 20mg

Rosuvastatin 5 to 10mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Statin Therapy (High intensity)

A

Atorvastatin 40 to 80mg

Rosuvastatin 20 to 40mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cholesterol Levels

A

Desirable: <200

Borderline: 200 to 239

High Risk: >240

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Triglycerides

A

Desirable: <150

Borderline: 150 to 199

High Risk: 200 to 499

17
Q

HDL Cholesterol

A

Desirable: 60

Borderline: 35 to 45

High Risk: <35

18
Q

LDL cholesterol

A

Desirable: 60 to 130

Borderline: 130 to 159

High Risk: 160 to 189

19
Q

BEFORE initiating a STATIN

A
  • Get baseline aminotransferase levels
    • In the presence of liver disease:
      • Pravastatin and Rosuvastatin are preferred
      • Alcohol abstinence is imperative
      • Start at a very low statin dose and titrate based on aminotransferase levels
        • Re-evaluate in 4 to 12 weeks and re-check aminotransferase levels
  • Check thyroid function (TSH)
    • Hypothyroidism is a potential cause for dyslipidemia and can make patients more susceptible to muscle injury
20
Q

Muscle Injury associated with statin use

A
  • Risk is highest with statins extensively metabolized by the cytochrome P450 3A4
21
Q
A
  • Risk is highest with statins extensively metabolized by the cytochrome P450 3A4
    • Examples: Lovastatin, Simvastatin, Atorvastatin
  • If muscle injury occurs:
    • STOP statin
    • Evaluate for potential contributing factors
      • Hypothyroidism
      • Vitamin D Deficiency
      • Medication interactions
    • Treatment options:
      • Restart at lower dose
      • Attempt alternate day dosing
      • Switch statin agents
      • Switch to non-statin cholesterol lowering agent.
22
Q

Hypertriglyceridemia (HTG)

A
  • Associated with an increased risk for cardiovascular events and acute pancreatitis
  • Occurs in approximately 25% of adults in the USA

Triglyceride Levels:
- Normal: < 150 mg/dL
- Moderate: 150 to 499 mg/dL
- Severe: 500 to 999 mg/dL

Risk factors:
- Insulin resistance, renal disease, hypothyroidism, diet with excess caloric intake, daily alcohol consumption, pregnancy, multiple myeloma, lupus and medications
- Medications: Thiazide diuretics, glucocorticoids, antivirals, second generation antipsychotics, beta blockers

Presentation:
- Generally asymptomatic, however some with moderate to severe HTG experience xanthomas

23
Q

Hypertriglyceridemia Treatment

A

General measures:
- Address modifiable causes
- Uncontrolled diabetes
- Hypertension management
- Improve nutrition and restrict alcohol intake
- Smoking cessation
- Treat dyslipidemia

Moderate HTG (150 to 499)
- High ASCVD risk
- Marine omega-3 fatty acid therapy (Icosapent ethyl)
- Without high risk for ASCVD
- General measure

Moderate to Severe HTG (500 to 999)
- High ASCVD ethyl
- Icosapent ethyl
- If unsuccessful, add a vibrate
- Without high risk for ASCVD
- Fibrat therapy
- If unsuccessful, add on omega-3 fatty acid

Severe HTG (>1000)
- Extreme dietary fat restriction, alcohol abstinence, fibrate

24
Q

High ASCVD risk

A

Established ASCVD or diabetes mellitus PLUS two additional ASCVD risk factors

  • Age >50 years, cigarette smoking, hypertension, HDL-C <40 for males or <50 for females, C-reactive protein >4, CrCl <60, retinopathy, micro or macroalbuminuria and ankle brachial index 0.9
25
Peripheral Artery Disease (PAD)
- Arteries that supply the limbs narrows, thereby reducing blood flow and perfusion Risk factors: - Hyperlipidemia, smoking, hypertension and diabetes Presentation: - Extremity ulceration - Arterial: Over toe joints, over the bones prominence of the malleoli, the anterior shin, or at the base of the heel. - Venous: Malleoli (above the bony prominence), and also over the posterior calf. - Neuropathic: Pressure points of the foot (plantar surface of the foot over the metatarsal heads and the heel) - Claudication: Reproducible discomfort of a defined group of muscles that is caused by exercise and relieved with rest. - Can occur with buttock, hip, thigh, calf, foot pain (alone or in combination) - Buttock and hip: Aortoiliac occlusion - Thigh: Aortoiliac or common femoral artery occlusion - Calf: Superficial femoral or popliteal artery Diagnosis: - An ankle-brachial systolic pressure index (ABI) of <0.90 has a high degree of sensitivity and specificity for a diagnosis of PAD
26
Peripheral Artery Disease (PAD) treatment
- Conservative measures: - Reducing cardiovascular risk factors - Reducing smoking - Exercise therapy - Pharmacological therapy: - Naftidrofuryl - Cilostzol - Surgical repair
27
Heart Failure (HF)
- Heart cannot pump blood efficiently, or only at the cost of high filling pressures - Most commonly acute HF is due to dysfunction of the left ventricle Classified by Ejection Fraction - HF with a LVEF <40% is known as HF with reduced EF (HFrEF) - HF with LVEF of 41-49% is HF with mid-range EF (HFmrEF) - HF with LVEF >50% may be cause by HF with preserved EF (HFpEF) or cardiomyopathy Risk factors: - Ischemia or infarction, uncontrolled hypertension, new onset or uncontrolled atrial fibrillation, excessive tachycardia, pulmonary embolism, uncontrolled diabetes, thyroid dysfunction and substance abuse. Presentation: - Classic symptoms: Dyspnea, fatigue, edema - Additional symptoms: exercise intolerance, unintentional weight loss, recurrent ventricular arrhythmias, hypotension and sign of inadequate perfusion.
28
Classification of Heart Failure patients
Class 1: Patients with cardiac disease but WITHOUT limitations during ordinary physical activity Class 2: Patients with cardiac disease and with SLIGHT limitations. Normal activity causes some fatigue and dyspnea, however patient is comfortable at rest. Class 3: Patients with cardiac disease and with MARKED limitations. These patients are comfortable ONLY at rest and less than normal activity causes dyspnea Class 4: Patients with cardiac disease and who experience symptoms if ANY physical activity occurs. Symptoms may also occur at REST.
29
CHF Diagnosis
- There is no gold standard for the diagnosis instead it is based on collection data to support the diagnosis Tests used to support the diagnosis: - History and physical exam - Echocardiogram, ECG, natriuretic peptide levels and a chest radiograph - Echo to assess cardiac dysfunction and identify possible cause - ECG to rule out arrhythmias, infarction - A normal ECG essentially rules out left sided heart failure - Natriuretic Peptide levels may be normal in patients with HF who have preserved ejection fraction and therefore it can be used to support a diagnosis of Hf. - Cardiomegaly, pleural effusion, Kerley B Lines Treatment: - Combination therapy: - Angiotensin Blocker (Angiotensin receptor blocker neprilysin inhibitor, or ACE inhibitor or ARB) - Preferably sacubitril-Valsartan - Beta Blocker - Preferably metoprolol, carvedilol or bisoprolol - Mineralcorticoid receptor antagonist - Preferably eplerenone rather than spironolactone - SGLT2 Inhibitor - Preferably dapagliflozin or empagliflozin - HF With fluid overload - Requires diuretic - Example of loops diuretics: Furosemide, Torsemide, or Bumetanide - Effects are dose dependent and include: - Diuresis - Ototoxicty (typically occurs with large doses given IV)
30
Atrial Fibrillation
- Irregularly irregular ventricular rhythm and the absence of distinct P waves Presentation: - Palpitations, tachycardia, fatigue, weakness, dizziness, lightheadedness, reduced exercise capacity, increased urination or mild dyspnea. Management: - Long term rate control: - Beta blocker - Non-Dihydropyridine CCB - Digoxin - Narrow therapeutic range: between 0.8 - 2 - Toxicity: Arrhythmias, gastrointestinal symptoms, confusion and vision changes. - Oral anticoagulants: - Direct oral anticoagulants - Examples: Direct thrombin inhibitor dabigatran (Pradaxa) and the direct factor Xa inhibitors Rivaroxaban (xarelto) and Apixaban (Eliquis) - Do not use in patients with severe kidney disease, pregnancy and with patients who have mechanical prosthetic heart valves. - Vitamin K antagonist (warfarin) - Use in patients with a mechanical heart valve - Warfarin for a prosthetic heart valve: 2.5-3.5 - Warfarin for Afib: 2.0-3.0
31
CHA2DS2-VASc Scoring System
- CHF: 1 point - HTN: 1 point - 75 years and older: 2 points - Diabetes: 1 point - History of stroke/TIA: 2 points - Vascular disease (prior MI, PAD, aortic plaque): 2 point - Age 65 to 74 years: 1 point - Female gender: 1 point - Max score: 9 - Oral anticoagulants recommended: - Males with 2 or more points - Females with 3 or more points
32
Murmurs
Sound caused by turbulent blood flow that is heard loudest at the point of origin Intensity Grade: - Grade I: The faintest audible murmur heard - Grade II: Soft murmur that is readily detectable - Grade III: Murmur louder than grade II but without a palpable thrill - Grade IV: Loud murmur WITH a palpable thrill - Grade V: Very loud murmur, audible with the stethoscope lightly placed not the chest and a palpable thrill - Grade VI: Loudest murmur, audible with the stethoscope off the chest and a palpable thrill Treatment: - An Echocardiogram should be done on all patients with a cardiac murmur, that have not already been diagnosed and evaluated with an Echo or for anyone who is symptomatic. REMEMBER: For/4 the thrill of it — Grave IV has a palpable thrill Aortic area: 2nd ICS, right of the sternum Pulmonic area: 2nd ICS, left of the sternum Tricuspid area: 4th and 5th ICS, left of the sternum Mitral area: Located at the apex (bottom), 5th ICS
33
Systolic Murmurs
Starts with or after S1 and terminates before or at S2 - Systolic murmurs are seen in approximately 60% of patients of which 90% have a normal Echo Examples: - Mitral Regurgitation: Holosystolic murmur that is classified as high pitched and is best heard with the diaphragm of the stethoscope with the patient lying in the left lateral decubitus position. - Holosystolic murmur: Begins with the first heart sound and extends to or through the heard sound. - May radiate to left axilla. - Aortic sclerosis or stenosis: Causes a mid systolic murmur that is best heard at the right 2nd ICS - May radiate to the carotid (neck) - Mitral Valve prolapse: Mot common cause of late systolic murmur and is best heard wit the diaphragm of the stethoscope over or just medial to the cardiac apex. - Most common cause of MVP is a “floppy valve” also referred to as Barlow’s Syndrome. - Tricuspid Regurgitation (rare): Best heard with the diaphragm of the stethoscope along the left lower sternal border. - Increases with inspiration which is also known as Carvallo’s Sign. - Midsystolic ejection murmur (typically benign) - Ventricular septal defect
34
Diastolic Murmurs
Almost always pathological and they occur at S2 or after and end before S1 Examples: - Mitral stenosis: Best hear with the bell of the stethoscope with the patient in the left lateral decubitus position - Mid diastolic murmur that has a rumbling quality - Pulmonic Regurgitation: Findings are based on the severity - Begins early in diastole and is typically best heard over the left 2nd and 3rd ICS - Aortic Regurgitation: Decrescendo murmur that is best heard wit the diaphragm of the stethoscope at the right 2nd ICS - High frequency and “blowing” effect - May be musical in quality and cause a “diastolic whoop” - May be more audible if the patient leans forward and hold their breath after a complete expiration - Tricuspid Stenosis: Most often inaudible and discovered accidentally on an Echo - Most commonly associated with rheumatic etiology
35
MS ARD and MR PASS
DIASTOLIC Murmurs M: Mitral S: Stensosi A: Aortic R: Regurgitation D: Diastolic SYSTOLIC Murmurs M: Mitral R: Regurgitation P: Physiologic A: Aortic S: Stenosis S: Systolic
36
Infective Endocarditis
An infection of one or more heart valves Risk factor: - Heart valve disease - Mechanical heart valve - Device such as a pacemaker - Immunocompromised patients - Person who use IV drugs Presentation: - Systemic symptoms - Fever, sweat or chills, body aches - Other symptoms - Janeway Lesions: Hemorrhagic macules found on the palms of the hand and sole of the feet that are not painful - Splinter hemorrhages: Small blood clots that appear as streaks under the nail plate - Osler nodes: Tender lesions on the finger pads and toe pads - Murmur: detected in approximately 85% of patients with IE